Insulin action in adipocytes leads to an increase in the steady-state number of cell surface glucose transporters and insulin-like growth factor II (IGF-II) receptors that appear to cycle continuously between the plasma membrane and a low-density membrane fraction. The IGF-ll receptor could be labeled to constant specific activity by incubating adipocytes with [32Plphosphate for 2 hr. The extent of phosphorylation of IGF-H receptors in plasma membranes and in low-density microsomes was compared using 125I. labeled IGF-II binding and immunoblotting to quantitate the receptors present in each fraction. Receptors in the plasma membrane fraction ofcontrol cells incorporated approximately 1 molecule of phosphate per IGF-ll binding site or 2 to 3 times more phosphate than was incorporated into IGF-II receptors in the low-density microsomes. Addition of insulin to labeled adipocytes did not change the specific activity of the vphosphate of ATP but produced a specific and sharp decrease in the 32P-phosphate content of IGF-ll receptors in the plasma membrane. No change due to insulin in the phosphorylation of receptors derived from low-density microsomes was observed.
IGF-II receptors from the plasma membrane was rapid in onset, paralleled the increase in the number ofIGF-iI receptors on the cell surface, and persisted for at least 30 min in the presence of insulin. Furthermore, when the effect of insulin to increase the number of IGF-ll receptors in the cell surface was prevented by cooling cells to 5C, the decrease in phosphorylation of plasma membrane receptors could still be observed, indicating that this latter effect is not secondary to receptor redistribution. These data indicate that insulin inhibits one or more IGF-ll receptor kinases or increases phosphatase activity, or both. Decreased phosphorylation of such insulinsensitive plasma membrane components as IGF-II receptors may play a role in increasing their steady-state cell surface concentration, perhaps by delaying their internalization.
One of the most important and well-studied effects of insulin is the rapid stimulation of hexose transport activity in muscle and fat cells. Cushman and Wardzala (1) as well as Suzuki and Kono (2) demonstrated that this increase in glucose transport is accompanied by a redistribution of hexose transporters from a low-density microsome fraction to the plasma membrane fraction of disrupted cells. These workers proposed that insulin action leads to the recruitment of intracellular hexose transporters to the cell surface membrane. This hypothesis has been confirmed by the direct demonstration that insulin causes increased expression of transporters on the cell surface of intact adipocytes (3) . We recently showed that another membrane component, the type II insulin-like growth factor (IGF) receptor, responds to insulin in a manner remarkably similar to the glucose transporter (4) . Thus, increased numbers of IGF-II receptors were found to reside in the plasma membrane fraction of insulin-treated adipocytes, whereas a concomitant decrease in low-density microsome receptors due to insulin action was apparent (4) . These data underscore the likelihood that insulin may be modulating hexose transporters and IGF-II receptors through a similar mechanism.
Recent studies on the transferrin receptor have suggested that increased phosphorylation of such membrane components might be associated with the process of internalization (5, 6) . These findings raise the possibility that this type of covalent modification may be a general mechanism through which the cycling of membrane components could be regulated. The aim of the present study was to determine whether a reversible phosphorylation of the IGF-II receptor may be involved in the pathway of its internalization and recycling to the plasma membrane and whether such phosphorylation might be a focal point for insulin action. The results presented in this paper show that the effect of insulin to increase the number of receptors on the cell surface is accompanied by a sharp and stable decrease in the specific activity of 32P in these receptors in the plasma membrane.
MATERIALS AND METHODS
Cell Isolation and Labeling. Male rats weighing 100-150 g were used (SD strain, Taconic Farms, Germantown, NY). Fat cells were isolated from the epididymal fat pads as described by Rodbell (7) in phosphate-free Hepes-buffered Krebs-Ringer solution, pH 7.4. For 32P-labeling experiments, 5 ml of the cell suspension (0.5-1 x 106 cells per ml) was incubated at 370C in 25-cm2 culture bottles with carrierfree [32P]orthophosphate (1 mCi/ml; 1 Ci = 37 GBq; New England Nuclear). Routinely, 10 nM insulin (porcine, Lilly) was added to each culture bottle after a 2-hour labeling period for the times indicated. In experiments designed to evaluate the influence of glucose metabolism on the effects of insulin, 5 mM glucose was present in the buffer throughout.
Plasma Membrane and Low-Density Microsome Preparations. Plasma membranes and low-density microsomes were prepared in 0.25 M sucrose/10 mM Tris-HCl/5 mM EDTA/1 mM phenylmethylsulfonyl fluoride/0.1 mM Na3VO5/50 mM NaF/50 mM Na2H2P207, pH 7.4, at 40C by differential centrifugation as described by McKeel and Jarett (8) , with some modifications (9) . Membrane protein determinations were carried out by the Bradford procedure (10) (Bio-Rad protein assay) using egg albumin (Sigma) as standard. These plasma membranes and low-density microsome fractions have previously been characterized in detail (1, 4 low density microsomes were solubilized in 500 1.l of 25 mM Hepes/1.5% Triton X-100/1% sodium deoxycholate/1% bovine serum albumin/0.1% NaDodSO4/5 mM EDTA/1 mM phenylmethylsulfonyl fluoride/0.1 mM Na3VO5/50 mM NaF/50 mM Na2H2P207/0.5 M NaCI (lysis buffer) and immunoprecipitated in a final volume of 1 ml with 15 jig of polyvalent antibody against the IGF-I1 receptor (9, 11) previously immobilized on Affi-Gel 10 (Bio-Rad). After incubating with constant mixing overnight the resin was extensively washed with lysis buffer. After a final wash with 25 mM Hepes/0.1% NaDodSO4/0.1% Triton X-100, the resin was boiled for 1 min in 50 mM Tris, pH 6.8/1% NaDodSO4/ 20%o glycerol/0.005% bromophenol blue. The solubilized samples were electrophoresed on 6% polyacrylamide slab gels as described by Laemmli (12) .
Immunoblotting. Immediately after electrophoresis, proteins were transferred from the gels onto nitrocellulose paper (Schleicher & Schuell), essentially as described by Burnette (13) The possibility that the effect of insulin to decrease the incorporation of [32P]phosphate into IGF-II receptors was a reflection of an insulin-mediated decrease in the specific activity of the y-phosphate of ATP rather than of a true decrease in the phosphorylation state of the receptor was considered. Therefore, the specific activity of the y-phosphate of ATP in adipocytes was measured under each of the experimental conditions tested. The results presented in Table 2 show that the ATP pool reached constant specific activity after =60 mih of incubation. The incorporation of 32p into the IGF-II receptor closely parallels the labeling of the y-phosphate of ATP. This evidence indicates that the phosphate groups of the IGF-II receptor turn over very rapidly.
When the values for specific activity of ATP (Table 2 ) and for receptor concentration calculated by Scatchard analysis of 125I-labeled IGF-II binding (0.4 0.2 pmol/mg of protein) are used, the calculated stoichiometry for the phosphorylation of plasma membrane IGF-II receptors is between 0.75 and 1.5 molecules of phosphate per IGF-II binding site. Addition of 10 nM insulin after a 120-min-labeling period did hot alter the specific activity of the y-phosphate of ATP to any detectable extent. Thus, the data indicate that the decrease in the (15) . In view of these data, experiments were performed to determine whether the decrease in the phosphorylation state of the IGF-II receptor was dependent on the stimulation of glucose metabolism induced by insulin. In the presence or absence of glucose, insulin caused a marked decrease in the phosphorylation state of the IGF-II receptor in the plasma membrane ( Table 2) .
The insulin-mediated decrease in the phosphorylation state of the plasma membrane IGF-II receptor coincides with the enrichment of this fraction with receptors from the lowdensity microsomal fraction. This raises the possibility that the decrease in phosphorylation of the IGF-II receptor in the plasma membrane fraction may be a consequence of dilution with less-phosphorylated receptors from the low-density microsomes. Two different experiments were performed to evaluate this possibility. First, the time course of the insulin effect was studied. If the possibility were correct, it would be predicted that the poorly phosphorylated receptors from the low-density microsomes upon being inserted into the plasma membrane would rapidly become as heavily phosphorylated as those receptors initially present in the plasma membrane.
Thus, the 32P/125I ratio would quickly return to the control values observed before addition of insulin. It was found that the increase in the number of IGF-II receptors in the plasma membrane occurs relatively quickly after the addition of insulin and is completed within 5 min of incubation with the hormone (Fig. 3A) . The decrease in the specific activity of 32p in IGF-II receptors of the plasma membrane is equally fast. However, the insulin-mediated decrease in the phosphorylation state of the plasma membrane IGF-II receptors is stable and remains virtually unchanged even after 30 min of incubation with the hormone. No change in the phosphorylation of IGF-II receptors in the low-density microsomes occurs throughout this time period (Fig. 3B) .
In the second experiment, use was made of the fact that, at low temperature, most events involving endocytosis or exocytosis are inhibited, while insulin binding to and activation of its receptor kinase are not (16) . It can be seen in Fig.  4 that the insulin-mediated increase in the number of plasma membrane IGF-II receptors, which is readily apparent at Time course of effect of insulin to produce redistribution of IGF-II receptors and decrease the phosphorylation state of the receptor in the plasma membrane. Cells were incubated for 2 hr with 32P at 1 mCi/ml. Insulin (10 nM) was added to each bottle and incubations were continued for the times indicated. The incubation medium was removed as quickly as possible and the cells were homogenized. The earliest time point that could be recorded, -1.2 min, was the shortest period of time between the addition of insulin and the homogenization of the cells. Plasma membranes (A) and low-density microsomes (B) were solubilized and the IGF-II receptor was immunoprecipitated, electrophoresed, and immunoblotted. l25l and 32P radioactivities in the receptor and the 32P/I251 ratios were quantitated as described in the legend to 37TC (A), is virtually abolished when the temperature is decreased to 5YC (B). However, the insulin-mediated decrease in the phosphorylation of the IGF-II receptor in the plasma membrane is equally apparent at 5YC as at 370C. Thus, insulin is capable of reducing the phosphorylation state of IGF-II receptors in the plasma membrane even under conditions in which the insertion of receptors from the lowdensity microsomes is prevented. (Fig. 2) . However, even after 30 min of insulin exposure equivalent to at least two rounds of IGF-II receptor recycling (17) , plasma membrane IGF-II receptors are still less phosphorylated compared to those in control cells (Fig.   3 ). Taken together, these data suggest that the presence of insulin markedly retards the phosphorylation of IGF-II receptors in the plasma membrane.
Third, the effect of insulin to decrease the phosphorylation state ofIGF-II receptors in the plasma membrane persists under conditions in which receptor redistribution is blocked (Fig. 4) . This evidence argues strongly against the possibility that the decrease in the phosphorylation of plasma membrane IGF-II receptors is only a reflection of the enrichment of this fraction with receptors from the low-density microsomes. Rather, the insulin-mediated inhibition of phosphorylation of plasma membrane IGF-II receptors could be a primary effect of the hormone.
We cannot distinguish from our data whether the decreased phosphorylation state of plasma membrane IGF-II receptors in response to insulin is due to an increase in phosphatase activity, a decrease in kinase activity, or both. However, it is known that the phosphorylation processes involved in the regulation of glycogen synthesis and pyruvate dehydrogenase activity are affected by insulin in a manner that implicates the stimulation of phosphatase activity (15, (18) (19) (20) . Regardless of the potential mechanism, it is clear that the effect of insulin to alter the dynamics of plasma membrane IGF-II receptor phosphorylation is closely associated with the redistribution of receptor that occurs on exposure of fat cells to the hormone.
The data presented here lead us to a working hypothesis on the mechanism by which insulin increases the steady-state number of cell surface IGF-I1 receptors. It is proposed that the inhibition of plasma membrane IGF-II receptor phosphorylation by insulin action delays the process whereby these receptors are directed to be internalized. According to this view, insulin action decreases the phosphorylation rate of one or more key sites on the IGF-II receptor involved in targeting the receptor toward an endocytotic pathway. Thus, by inhibiting an IGF-II receptor kinase or stimulating a phosphatase, insulin would shift the kinetics of receptor recycling such that an increased steady-state number of receptors would reside in the cell surface membrane. This hypothetical mechanism could operate in the absence of a direct effect of insulin on the cellular exocytotic or endocytotic processes. However, such effects of insulin on general endocytosis or exocytosis cannot be excluded (21) . In any case, studies directed toward characterizing the kinases and phosphatases that regulate the phosphorylation state of the IGF-II receptor and their roles as targets for insulin action will be of great interest.
